ISO 5832-3 (Implants for Surgery — Metallic Materials — Part 3: Wrought Titanium-6Aluminum-4Vanadium ELI Alloy) and ASTM F136 (Standard Specification for Wrought Titanium-6Aluminum-4Vanadium ELI Alloy for Surgical Implant Applications) serve the same engineering function — defining the chemical composition, mechanical properties, and testing requirements for Ti-6Al-4V ELI used in implantable medical devices. Both standards specify equivalent oxygen limits (0.13 percent maximum) and nearly identical mechanical property minima. The practical differences between them are not in the material they describe but in the regulatory and certification frameworks in which they are referenced. ASTM F136 is the governing standard for FDA-regulated medical devices in the United States. ISO 5832-3 is the referenced standard for CE-marked devices under the Medical Device Regulation (MDR) in Europe and for devices registered in other markets that follow ISO-based regulatory frameworks. Understanding when each standard applies, which certification documents are required by each, and whether a single material lot can be certified to both standards simultaneously is essential for any procurement team sourcing implant-grade titanium for global distribution. For a detailed explanation of the ASTM F136 standard itself — its composition limits, property tables, and certification requirements — see the ASTM F136 standard guide. For a broader overview of all medical implant titanium standards, see the medical titanium implants manufacturing standards article and the Grade 23 titanium guide.
What ISO 5832-3 and ASTM F136 Actually Cover
Both standards are raw material specifications — they define what constitutes acceptable Ti-6Al-4V ELI material for implant manufacturing, not how the finished implant component should be designed, manufactured, or tested. The scope of both standards is limited to wrought product forms: bar, billet, sheet, strip, plate, and wire.
| Aspect | ASTM F136 | ISO 5832-3 |
|---|---|---|
| Full title | Standard Specification for Wrought Titanium-6Aluminum-4Vanadium ELI Alloy for Surgical Implant Applications | Implants for Surgery — Metallic Materials — Part 3: Wrought Titanium-6Aluminum-4Vanadium ELI Alloy |
| Designation | UNS R56401 | No equivalent UNS designation; typically referenced as “Ti-6Al-4V ELI” |
| Issuing body | ASTM International (United States) | International Organization for Standardization (Geneva, Switzerland) |
| Regulatory framework referenced | FDA guidance documents, 21 CFR Part 820 | EU Medical Device Regulation (MDR) 2017/745, ISO 13485 |
| Editions | Active standard with periodic revisions (current edition: ASTM F136-13) | Active standard with periodic revisions (current edition: ISO 5832-3:2021) |
| Scope | Wrought ELI titanium for surgical implants | Wrought ELI titanium for surgical implants |
The scope overlap is essentially complete. A material lot that meets ASTM F136 will also meet ISO 5832-3 in almost all cases — and vice versa. The differences are in the tolerances and testing frequencies, not in the fundamental material requirements.
Chemical Composition: Are the Limits Identical?
The short answer: yes, for practical purposes. The long answer: there are minor numerical differences in some element limits that rarely affect material acceptance.
Table 1: Composition comparison — ASTM F136 vs ISO 5832-3 (percent by weight)
| Element | ASTM F136 (max % unless noted) | ISO 5832-3 (max % unless noted) | Difference |
|---|---|---|---|
| Oxygen, max | 0.13 | 0.13 | None — the critical ELI limit is identical |
| Nitrogen, max | 0.05 | 0.05 | None |
| Carbon, max | 0.08 | 0.08 | None |
| Hydrogen, max | 0.015 (bar), 0.012 (sheet/plate) | 0.015 | ASTM F136 distinguishes bar from sheet; ISO 5832-3 uses a single limit |
| Iron, max | 0.25 | 0.25 | None |
| Aluminum | 5.5–6.5 | 5.5–6.5 | None |
| Vanadium | 3.5–4.5 | 3.5–4.5 | None |
| Residuals, each max | 0.10 | 0.10 | None |
| Residuals, total max | 0.40 | 0.40 | None |
The only substantive difference is in the hydrogen limit for sheet and plate: ASTM F136 specifies a tighter limit (0.012 percent) for sheet product forms, while ISO 5832-3 applies the same 0.015 percent limit to all product forms. In practice, the difference is negligible — hydrogen content in properly processed Ti-6Al-4V ELI is typically below 0.008 percent regardless of the specification.
Mechanical Properties: Minor Variations in Requirements
Table 2: Mechanical property comparison — ASTM F136 vs ISO 5832-3
| Property | ASTM F136 (annealed, min) | ISO 5832-3 (annealed, min) | Difference |
|---|---|---|---|
| Tensile strength, min | 860 MPa (125 ksi) | 860 MPa | Identical |
| Yield strength, 0.2% offset, min | 795 MPa (115 ksi) | 795 MPa | Identical |
| Elongation, min | 10% | 10% | Identical |
| Reduction of area, min | 25% | 25% | Identical |
| Fracture toughness (when specified) | No explicit requirement in standard | No explicit requirement in standard | Neither standard mandates KIC testing — it is a supplementary requirement |
The mechanical property requirements are identical. Both standards specify the same minimum values for tensile strength, yield strength, elongation, and reduction of area. Neither standard requires fracture toughness testing as a routine acceptance criterion — fracture toughness verification is a supplementary requirement typically added by the implant manufacturer’s procurement specification, not by the material standard itself.
Where the standards differ in practice
The material requirements may be identical, but the regulatory expectations around certification differ:
Certification documentation: ASTM F136 references EN 10204 for certification requirements in its supplementary requirements section, but does not mandate a specific certification level. In practice, FDA-regulated devices require material with documented test results — effectively EN 10204 Type 3.1 or equivalent. ISO 5832-3 is typically referenced in conjunction with ISO 13485 quality system requirements, which mandate documented material verification as part of the device history record. Both frameworks effectively require the same level of documentation.
Testing frequency: ASTM F136 specifies testing frequency per lot — one tensile test per 100 kg or fewer for bar stock, one per 500 kg or fewer for sheet and plate. ISO 5832-3 specifies testing frequency as “one test per lot” with lot defined as the same mill heat. In practice, mill testing frequencies under both standards are equivalent.
Retest provisions: ASTM F136 has explicit retest provisions — if a test fails, two additional tests from the same lot are permitted, and if both pass, the lot is accepted. ISO 5832-3 does not have explicit retest provisions in the same format, but retesting per the supplier’s quality system and the implant manufacturer’s incoming inspection procedures is standard practice under both frameworks.
Regulatory Acceptance by Market
The practical difference between ISO 5832-3 and ASTM F136 emerges when the same implant device is distributed in multiple regulatory jurisdictions.
Table 3: Regulatory acceptance of material standards by market
| Market | Applicable regulation | Preferred implant material standard | Can material certified to the other standard be used? |
|---|---|---|---|
| United States | FDA 21 CFR Part 820, QSR | ASTM F136 | Yes — but equivalence must be documented in the device design history file |
| European Union | EU MDR 2017/745 | ISO 5832-3 | Yes — but material certified to ASTM F136 must demonstrate equivalence per notified body review |
| Canada | Health Canada SOR/98-282 | ASTM F136 or ISO 5832-3 | Both accepted |
| Japan | MHLW, JPAL | ISO 5832-3 (JIS T 7401-3 is the domestic adoption) | ASTM F136 material requires JPAL equivalency documentation |
| China | NMPA (formerly CFDA) | GB/T 13810 (domestic adoption of ISO 5832-3) | ASTM F136 material requires GB/T equivalency demonstration |
| Australia | TGA | ISO 5832-3 | ASTM F136 material requires TGA acceptance per device submission |
| Brazil | ANVISA | ASTM F136 or ISO 5832-3 | Both accepted |
For a medical device company sourcing titanium for a hip stem that will be sold in the United States, Germany, Japan, and Australia, the procurement specification must accommodate material certified to either ASTM F136 or ISO 5832-3 — or, more practically, require material that is certified to both standards simultaneously.
Can a Single Material Lot Be Certified to Both Standards?
Yes — and this is the standard practice for mill suppliers serving the global medical implant market. Major titanium mills — VSMPO-Avisma, TIMET, ATI, and Baoji suppliers serving medical device OEMs —typically produce Ti-6Al-4V ELI material that meets both ASTM F136 and ISO 5832-3 with a single production lot. The mill test report will state compliance with both standards.
The practical requirement for the procurement team is simple: the purchase order must specify both standards by name. For example:
“Ti-6Al-4V ELI per ASTM F136 and ISO 5832-3, EN 10204 Type 3.1 certification, product form: annealed bar, diameter 25.4 mm (1.000 in).”
Material meeting both standards from a single mill lot typically carries a material cost premium of less than 5 percent compared to material certified to a single standard. The premium covers the additional testing and documentation required to demonstrate compliance with both standards — primarily the documentation effort, not the material properties.
Three Practical Rules for ISO 5832-3 vs ASTM F136 Procurement
Rule 1: If distribution is global, specify both standards in the purchase order.
A hip stem sold in the United States with an ASTM F136 material certification requires additional equivalence documentation for CE-marking under EU MDR. A hip stem sold in the European Union with ISO 5832-3 certification requires additional equivalence documentation for FDA submission. Specifying both standards on the purchase order eliminates this duplication. The incremental certification cost for dual-standard material is typically 3–5 percent of the material cost — significantly less than the cost of re-certification or regulatory resubmission.
Rule 2: Verify that the certification level is adequate before the order, not during receiving inspection.
Both standards are commonly supplied with EN 10204 Type 3.1 certification (mill test report with actual test results). However, some distributors supply material with Type 2.2 certification (declaration of compliance without test data) at a lower price. For implant manufacturers operating under ISO 13485 or FDA QSR, Type 2.2 documentation is typically not acceptable because it does not provide the documented verification data required by the device history record. Specify Type 3.1 (minimum) in the purchase order and verify that the supplier’s standard certification level meets this requirement.
Rule 3: Confirm the beta transus temperature if heat treatment is planned — neither standard requires it on the MTR.
Neither ASTM F136 nor ISO 5832-3 requires the supplier to report beta transus temperature on the mill test report. If the implant design requires solution treatment and aging (STA) or any thermal processing that depends on knowing the beta transus, request this data from the mill as a supplementary requirement. The beta transus of Ti-6Al-4V ELI is typically 980–1,010°C, approximately 10–20°C lower than standard Grade 5 due to reduced oxygen content.
For medical device engineering teams and procurement professionals sourcing implant-grade titanium for global distribution, confirming that the material is certified to both ASTM F136 and ISO 5832-3 (when multi-market distribution is planned) and that the supplier provides EN 10204 Type 3.1 documentation as standard practice will prevent the most common regulatory documentation gaps. A titanium CNC machining and fabrication partner with documented medical-device material sourcing experience across both standards can provide the certification support needed for global regulatory compliance.
For a quotation on dual-standard-certified Grade 23 components with full certification documentation for your target regulatory markets, submit your requirements through our RFQ portal.